CVS Health Corporation (CVS) Stock Forecast
CVS analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 4.59 / 5 from 27 analysts
- Price target
- $115.48 average of analyst targets
- Upside to target
- +25.0% from the latest close
- Next earnings
- November 4, 2026 EPS estimate $1.62
- 52-week range
- $70.08 – $110.60
CVS analyst ratings
27 analystsNumber of analysts at each rating.
CVS price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
CVS earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.65 | $1.52 | $1.87 | $1.60 | +3.2% | 23 |
| Current fiscal year (2026) | $8.04 | $7.94 | $8.15 | $6.75 | +19.1% | 25 |
| Next fiscal year (2027) | $8.54 | $8.43 | $9.05 | $8.04 | +6.1% | 26 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
CVS revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $104.80B | $102.35B | $108.94B | +1.9% | 18 |
| Current fiscal year (2026) | $418.04B | $414.06B | $427.32B | +4.0% | 21 |
| Next fiscal year (2027) | $430.06B | $410.66B | $451.27B | +2.9% | 22 |
CVS EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
CVS revenue: reported and forecast
CVS EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.71 | $1.64 | $1.61 | $1.63 | $1.65 | −3.6% | 5 up · 1 down |
| Current fiscal year (2026) | $7.44 | $7.95 | $8.02 | $8.04 | $8.04 | +8.0% | 3 up · 2 down |
| Next fiscal year (2027) | $8.41 | $8.50 | $8.52 | $8.53 | $8.54 | +1.5% | 4 up · 2 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
CVS earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; CVS beat in 10 of 12.
What analysts expect from CVS
27 analysts cover CVS Health; their consensus rating is strong buy (4.59 on a 1–5 scale, where 5 is a strong buy). The average price target is $115.48, 25.0% above the latest close of $92.36. Analysts expect earnings of $8.04 per share for 2026, +19.1% from a year earlier. For 2027 the average estimate is $8.54 per share on revenue of $430.1 billion. CVS Health beat the EPS estimate in 10 of the last 12 quarters.
Related: CVS income statement, CVS key metrics, CVS chart. See the CVS stock overview for the latest quote and news.
CVS forecast FAQ
What is CVS Health's price target?
The average analyst price target for CVS Health is $115.48, 25.0% above the latest close of $92.36.
Is CVS Health a buy, hold or sell?
Of 27 analysts covering CVS Health, 18 rate it a strong buy, 7 a buy, 2 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is CVS Health's EPS forecast?
Analysts forecast $8.04 per share for 2026 (range $7.94 to $8.15); for 2027 the estimate is $8.54.
What is CVS Health's revenue forecast?
The average revenue estimate for 2026 is $418.0 billion, growth of 4.0%; for 2027 it is $430.1 billion.
When does CVS Health report earnings?
CVS Health is expected to report results for the quarter ending September 30, 2026 on November 4, 2026 before the market opens; the EPS estimate is $1.62.
Does CVS Health usually beat earnings estimates?
CVS Health reported EPS at or above the analyst estimate in 10 of the last 12 quarters.